Sands Capital Closes Third Life Sciences Fund at $555M

Fund to Focus on Transformative Healthcare Technologies

Sands Capital has successfully closed its third life sciences fund, Life Sciences Pulse Fund III, raising $555 million. This fund brings Sands Capital's total life sciences assets under management to $1.3 billion across three funds. The new fund will target private therapeutics, diagnostics, medical devices, and life sciences tools, continuing the firm’s mission to transform disease definition, diagnosis, and treatment.